Clinical trials recruited hundreds of thousands of patients, while families in lockdown waited, hoping for regulatory approval of a COVID-19 vaccine that w...
Artificial Intelligence in Healthcare In healthcare, AI has the potential to drive scientific breakthroughs, aid in diagnosis, treatment, and management o...
Lyme disease is the most common vector-borne illness in the United States.2 And yet, the actual cases are vastly underreported. The U.S. Centers for Diseas...
Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Applications (sNDAs) fo...
Mabwell (688062.SH), an innovative biopharmaceutical company with the whole industry chain layout, announced its Nectin-4 targeted site-specific ADC asset ...
BCs’ Act at the centre of this case aims to preserve a publicly-funded health care system where access to necessary medical care is based on patients...
Preclinical data demonstrate the efficacy of TNX‐801 vaccination against mpox virus challenge in a non-human primate model Phase 1 trial with TN...
Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), announced that the U.S. Food and Drug Admini...
As product performance and patient safety are central to our values, PerkinElmer is fully prepared to comply with this important transition. If you are a ...
Although hybridoma technology remains one of the most common techniques for antibody production, the generation and screening of hybridomas can be time-con...
Cancer is one of the leading causes of death across Asian countries. According to a report published by Janssen Asia Pacific, in 2017, overall, there wer...
The rising prevalence of chronic diseases coupled with increasing research activities for cell-based research is found to be the major factor driving the...
According to the Global Cancer Observatory, in Saudi Arabia there are 830 new kidney cancer cases were registered in 2018, furthermore, 249 people were d...
The U.S. Department of Health and Human Services plans to end the federal COVID-19 Public Health Emergency on May 11, but ensuring access to novel vac...
© 2025 Biopharma Boardroom. All Rights Reserved.
